A 38-year-old woman from Bangalore presents with a 6-month history of persistent nasal obstruction, postnasal drip, and mild facial pressure. She denies fever or acute pain. Nasal endoscopy reveals pale, boggy mucosa with small nasal polyps in the ostiomeatal complex bilaterally. CT paranasal sinuses shows diffuse mucosal thickening (>4 mm) in all sinuses without air-fluid levels or bone erosion. She has a 10-year history of allergic rhinitis managed with antihistamines. What is the most appropriate next step in management?

Explanation

## Diagnosis: Chronic Rhinosinusitis (CRS) with Allergic Component ### Clinical Presentation Analysis **Key Point:** Chronic sinusitis is defined as symptoms persisting ≥12 weeks with imaging evidence of sinus inflammation, but WITHOUT acute exacerbation features (fever, purulent discharge, air-fluid levels). This patient meets criteria: - Duration: **6 months** (well beyond 12 weeks) - Symptoms: Nasal obstruction, postnasal drip, mild facial pressure (no fever) - Imaging: Diffuse mucosal thickening without air-fluid levels or acute changes - Endoscopy: Pale, boggy mucosa with polyps — classic chronic appearance ### Differential Features | Feature | Acute Sinusitis | Chronic Sinusitis | |---------|-----------------|-------------------| | Duration | <4 weeks | ≥12 weeks | | Fever | Present | Absent | | Purulent discharge | Copious, yellow-green | Scanty, mucoid | | Mucosal appearance | Edematous, hyperemic | Pale, boggy, fibrotic | | Air-fluid levels | Present | Absent | | Nasal polyps | Rare | Common | ### Management Algorithm for Chronic Sinusitis ```mermaid flowchart TD A[Chronic Sinusitis Diagnosed]:::outcome --> B[First-line: Medical Management]:::action B --> C[Topical nasal corticosteroid]:::action C --> D[Nasal saline irrigation]:::action D --> E[Treat comorbidities: allergies, asthma]:::action E --> F{Response after 4-6 weeks?}:::decision F -->|Good response| G[Continue maintenance therapy]:::action F -->|Poor response| H[Consider CT + Specialist review]:::decision H -->|Refractory disease| I[Functional Endoscopic Sinus Surgery]:::action H -->|Modifiable factors| J[Optimize allergy control, address obstruction]:::action ``` ### Why Topical Corticosteroids Are First-Line **High-Yield:** The 2021 EPOS (European Position Paper on Rhinosinusitis) and AAOHNS guidelines recommend topical nasal corticosteroids as the first-line pharmacologic therapy for chronic rhinosinusitis. **Mechanism:** 1. Reduces mucosal edema and inflammation 2. Decreases mucus production 3. Restores mucociliary clearance 4. Shrinks nasal polyps (if present) 5. Minimal systemic absorption **Clinical Pearl:** Saline irrigation (hypertonic or isotonic) enhances mucociliary clearance and removes inflammatory mediators — synergistic with corticosteroids. ### Addressing the Allergic Component This patient has a **10-year history of allergic rhinitis**, which is a major risk factor for chronic sinusitis. Allergic inflammation perpetuates ostiomeatal complex obstruction. **Recommendation:** Continue or optimize antihistamine therapy; consider intranasal corticosteroid (which addresses both allergies and sinusitis). ### Why Surgery Is NOT the Next Step **Warning:** Functional endoscopic sinus surgery (FESS) is reserved for **refractory disease** after 4–6 weeks of optimized medical therapy. This patient has not yet been given a trial of first-line medical management. ### Why Antibiotics Are NOT Indicated - No fever or acute exacerbation - No purulent discharge - Chronic sinusitis is not primarily bacterial; it is a chronic inflammatory condition - Antibiotics have no role in uncomplicated chronic sinusitis [cite:EPOS 2020] [cite:Dhingra 7e Ch 11; EPOS 2020 Guidelines]